Literature DB >> 4850526

An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.

S Lal, C H Dash, M D Gribben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4850526      PMCID： PMC470152          DOI： 10.1136/thx.29.3.317

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  FORCED EXPIRATORY TIME: A SIMPLE TEST FOR AIRWAYS OBSTRUCTION.

Authors:  S LAL; A D FERGUSON; E J CAMPBELL
Journal:  Br Med J       Date:  1964-03-28

2.  Maximum forced expiratory flow rate as a measure of ventilatory capacity: with a description of a new portable instrument for measuring it.

Authors:  B M WRIGHT; C B McKERROW
Journal:  Br Med J       Date:  1959-11-21

3.  Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol.

Authors:  B J Freedman
Journal:  Br J Dis Chest       Date:  1972-07

4.  The bronchodilator effect of a new adrenergic aerosol--Salmefamol.

Authors:  M C Kennedy; C H Dash
Journal:  Acta Allergol       Date:  1972-02

5.  New class of selective stimulants of beta-adrenergic receptors.

Authors:  D Hartley; D Jack; L H Lunts; A C Ritchie
Journal:  Nature       Date:  1968-08-24       Impact factor: 49.962

6.  Clinical comparison of inhaled terbutaline and orciprenaline in asthmatic patients.

Authors:  H Formgren
Journal:  Scand J Respir Dis       Date:  1970

7.  Clinical assessment of bronchodilator drugs delivered by aerosol.

Authors:  G M Shenfield; J W Paterson
Journal:  Thorax       Date:  1973-03       Impact factor: 9.139

8.  Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma.

Authors:  Y F Choo-Kang; W T Simpson; I W Grant
Journal:  Br Med J       Date:  1969-05-03
  8 in total
  2 in total

1.  Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.

Authors:  I A Campbell; C H Dash; G J McHardy; M V Shotter
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  A trial of clenbuterol in bronchial asthma.

Authors:  G Anderson; E Wilkins
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.